CVS Health Stock Price, News & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, October 3rd. Shareholders of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 annualized dividend and a yield of 3.18%. The ex-dividend date of this dividend is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its earnings results on Wednesday, August, 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, topping analysts' consensus estimates of $1.70 by $0.19. The pharmacy operator had revenue of $63.43 billion for the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. CVS Health's revenue was up 35.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.69 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus estimate of $6.84.

27 equities research analysts have issued 12-month price targets for CVS Health's shares. Their predictions range from $61.00 to $95.00. On average, they anticipate CVS Health's stock price to reach $75.39 in the next year. This suggests a possible upside of 19.7% from the stock's current price. View Analyst Price Targets for CVS Health.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have trended positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a news sentiment score of 2.3 on InfoTrie's scale. They also assigned media headlines about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Verizon Communications (VZ), Home Depot (HD), Intel (INTC) and Micron Technology (MU).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.09%), Artemis Investment Management LLP (0.05%), Country Trust Bank (0.04%), Cacti Asset Management LLC (0.04%), Polaris Greystone Financial Group LLC (0.04%) and Gillespie Robinson & Grimm Inc. (0.03%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL, State of Alaska Department of Revenue, Hexavest Inc., Verity & Verity LLC, TIAA FSB, Gyroscope Capital Management Group LLC, Crossmark Global Holdings Inc. and Community Trust & Investment Co.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Polaris Greystone Financial Group LLC, Country Trust Bank, Hartwell J M Limited Partnership, Gillespie Robinson & Grimm Inc., Bogart Wealth LLC, Neville Rodie & Shaw Inc. and Altman Advisors Inc.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $62.99.

CVS Health has a market capitalization of $81.92 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]